Providing patient information leaflets following COVID-19 treatment

Nicola Wake, Specialist Pharmacist: Lead Medication Safety, Specialist Pharmacy ServicePublished

Following treatment for COVID-19 with tocilizumab, sarilumab, or steroids, clinicians should provide suitable patient information leaflets at discharge

Purpose

Forms attached to this page can be used by clinicians with patients to support the discharge process.

The materials have been developed in conjunction with Dhivya Subramaniam, NHS England and NHS Improvement.

Form for discharging clinician

The attached form can be printed and completed by discharging clinicians before being handed to patients.

Patient discharge information for steroids

The attached form can be printed and handed to patients discharged following treatment with steroids.

Patient discharge information for tocilizumab or sarilumab

The attached form can be printed and handed to patients discharged following treatment with tocilizumab or sarilumab.